These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35750276)

  • 81. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
    Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
    Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Assaying for Radioresistant DNA Synthesis, the Hallmark Feature of the Intra-S-Phase Checkpoint Using a DNA Fiber Technique.
    Kijas AW; Lavin MF
    Methods Mol Biol; 2017; 1599():13-23. PubMed ID: 28477108
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Checkpoint Activation of an Unconventional DNA Replication Program in Tetrahymena.
    Sandoval PY; Lee PH; Meng X; Kapler GM
    PLoS Genet; 2015 Jul; 11(7):e1005405. PubMed ID: 26218270
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Gli1 protein regulates the S-phase checkpoint in tumor cells via Bid protein, and its inhibition sensitizes to DNA topoisomerase 1 inhibitors.
    Tripathi K; Mani C; Barnett R; Nalluri S; Bachaboina L; Rocconi RP; Athar M; Owen LB; Palle K
    J Biol Chem; 2014 Nov; 289(45):31513-25. PubMed ID: 25253693
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Therapeutic Targeting of DNA Replication Stress in Cancer.
    Gu L; Hickey RJ; Malkas LH
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510250
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Cancer Cell Selective Replication Stress Nano Amplifier Promotes Replication Fork Catastrophe to Overcome Radioresistance.
    Liao H; Yang S; Liang Z; Xiao L; Xie S; Lin P; Xia F; Fang C; Chen Q; Ling D; Li F
    ACS Nano; 2023 Sep; 17(18):18548-18561. PubMed ID: 37706454
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer.
    Zhang J; Chan DW; Lin SY
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359297
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Circular RNAs in cholangiocarcinoma.
    Liao W; Feng Q; Liu H; Du J; Chen X; Zeng Y
    Cancer Lett; 2023 Jan; 553():215980. PubMed ID: 36336149
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Replication stress as a driver of cellular senescence and aging.
    Herr LM; Schaffer ED; Fuchs KF; Datta A; Brosh RM
    Commun Biol; 2024 May; 7(1):616. PubMed ID: 38777831
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence.
    Buchynska L; Gordiienko I; Glushchenko N; Iurchenko N
    PLoS One; 2024; 19(4):e0302075. PubMed ID: 38669256
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ceramide kinase-mediated C1P metabolism attenuates acute liver injury by inhibiting the interaction between KEAP1 and NRF2.
    Dong W; Li Q; Lu X; Lan J; Qiu Z; Wang X; Wang J; Zheng X; Chen S; Zhang C; Jin J
    Exp Mol Med; 2024 Apr; 56(4):946-958. PubMed ID: 38556546
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity.
    Hamidi M; Eriz A; Mitxelena J; Fernandez-Ares L; Aurrekoetxea I; Aspichueta P; Iglesias-Ara A; Zubiaga AM
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230876
    [TBL] [Abstract][Full Text] [Related]  

  • 93. DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress response.
    Lin YF; Shih HY; Shang Z; Matsunaga S; Chen BP
    Nucleic Acids Res; 2014 Apr; 42(7):4463-73. PubMed ID: 24500207
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53.
    Segeren HA; van Liere EA; Riemers FM; de Bruin A; Westendorp B
    Oncogene; 2022 May; 41(19):2719-2733. PubMed ID: 35393546
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Dormant origin signaling during unperturbed replication.
    Moiseeva TN; Bakkenist CJ
    DNA Repair (Amst); 2019 Sep; 81():102655. PubMed ID: 31311769
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication.
    Moiseeva TN; Yin Y; Calderon MJ; Qian C; Schamus-Haynes S; Sugitani N; Osmanbeyoglu HU; Rothenberg E; Watkins SC; Bakkenist CJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13374-13383. PubMed ID: 31209037
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mechanisms used by cancer cells to tolerate drug-induced replication stress.
    Segeren HA; Westendorp B
    Cancer Lett; 2022 Sep; 544():215804. PubMed ID: 35750276
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Emerging strategies for cancer therapy by ATR inhibitors.
    Yano K; Shiotani B
    Cancer Sci; 2023 Jul; 114(7):2709-2721. PubMed ID: 37189251
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.